The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it

BACKGROUND: Apolipoprotein CIII (apoCIII) is considered to impair the anti-atherogenic effect of high density lipoprotein (HDL) in coronary heart disease (CHD) patients, and apoCIII content in HDL (HDL-apoCIII) predicts CHD more accurately. However, the relationship between HDL-apoCIII and CHD, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Xiaowei, Liu, Hong, Hua, Lu, Zhao, Hui, Wang, Dongxue, Li, Yishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600316/
https://www.ncbi.nlm.nih.gov/pubmed/26452348
http://dx.doi.org/10.1186/s12944-015-0129-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600316/
https://www.ncbi.nlm.nih.gov/pubmed/26452348
http://dx.doi.org/10.1186/s12944-015-0129-8

Ejemplares similares